SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: chirodoc who wrote (1170)9/17/1998 8:09:00 AM
From: billy d  Read Replies (1) of 10280
 
The way I see it, Barberich's answer to the question of companies making the new drugs in a fashion that need not be improved is something the street already knows. The selling yesterday was more then expected and I feel it held up quite well considering a 6 point up move the prior day.

This said, IMO, it doesn't matter.Relative to other biotechs, SEPR's current pipeline is so deep that the possible royalties from these products alone is mind boggling!

This is one of the few points that SEPR bears use but when you are talking 10 billion market for their pipeline its irrelevant. When you have the kind of revenues that SEPR should be getting, R and D for new drugs will be the next platform for this company.

Although Barberich was not exciting, he told it like it is and IMO was very credible. Nice job Tim.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News